Search Results for keywords:"Public Feedback"

The Food and Drug Administration (FDA) has released a draft guidance for companies developing drugs and biological products aimed at preventing and treating chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients. CIPN is a painful condition that can disrupt chemotherapy, affecting patients' survival by leading to treatment interruptions or dose reductions. The guidance offers recommendations for clinical trials, including the selection of trial participants and appropriate study endpoints. The public is encouraged to provide feedback on the draft by March 18, 2025, to help shape the final version.

The Federal Transit Administration (FTA) of the Department of Transportation has announced the availability of final policy guidance for the Capital Investment Grants (CIG) program. This guidance updates the initial policy from January 2023 and incorporates public feedback from earlier in 2024. It provides details about the steps and criteria projects must meet to qualify for discretionary funding. Certain projects already in progress may continue under the old guidance, but they can opt to switch to the new guidelines if they choose.

The Pipeline and Hazardous Materials Safety Administration (PHMSA) is seeking public feedback on its proposed tests for composite overwrapped pressure vessels (COPVs) with different pressure relief devices (PRDs). These tests aim to help develop better safety guidelines for COPVs, especially those transporting flammable gases, by assessing the effectiveness of PRDs under fire conditions. The agency invites comments on the proposed test setups, including the duration of bonfire tests, the adequacy of sample size, and the selection of PRDs. PHMSA also asks for input on the potential impacts of using thermal activation PRDs compared to pressure/temperature-activated ones.

The Department of Homeland Security (DHS), through U.S. Immigration and Customs Enforcement (ICE), has announced a notice about extending an information collection related to the Training Plan for STEM Optional Practical Training (OPT) students. This information collection involves Form I-983, which is a planning document filled out by both the student and their employer, detailing the terms and conditions of the student's practical training in science, technology, engineering, and mathematics (STEM) fields. Feedback from the public is invited until May 19, 2025, to ensure the data collection is beneficial and its methods are accurate. The goal is to reformat the form to better collect contact and compensation information while reducing the burden on respondents.

The Food and Drug Administration (FDA) has released a draft guidance document titled "Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)." This document provides general advice on evaluating donor eligibility, including screening and testing procedures. It also updates existing guidelines and plans to introduce additional guidance to help minimize communicable disease risks from donors. Public feedback on these recommendations can be submitted electronically or in writing until February 6, 2025.